Global Patent Index - EP 4277613 A1

EP 4277613 A1 20231122 - PHARMACEUTICAL COMPOSITIONS FOR TREATING BREAST CANCERS AND METHODS OF USES THEREOF

Title (en)

PHARMACEUTICAL COMPOSITIONS FOR TREATING BREAST CANCERS AND METHODS OF USES THEREOF

Title (de)

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON BRUSTKREBS UND VERFAHREN ZUR VERWENDUNG DAVON

Title (fr)

COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE CANCERS DU SEIN ET LEURS MÉTHODES D'UTILISATION

Publication

EP 4277613 A1 20231122 (EN)

Application

EP 22740195 A 20220114

Priority

  • US 202117151108 A 20210115
  • US 2022012631 W 20220114

Abstract (en)

[origin: WO2022155543A1] This invention relates to the treatment of breast cancer in a subject. Including methods of: treating by first determining the 18F-16Beta-fluoro-5alpha-dihydrotestosterone (18F-DHT) tumor uptake and identifying said subject as having AR-positive breast cancer based on F-DHT tumor uptake, comprising administering to the subject a therapeutically effective amount of a selective androgen receptor modulator (SARM) compound and a cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor.

IPC 8 full level

A61K 31/167 (2006.01); A61K 31/277 (2006.01); A61K 35/00 (2006.01)

CPC (source: EP IL KR)

A61K 31/167 (2013.01 - KR); A61K 31/277 (2013.01 - EP IL KR); A61K 31/506 (2013.01 - EP IL KR); A61K 31/519 (2013.01 - EP IL KR); A61K 45/06 (2013.01 - EP IL KR); A61P 35/00 (2018.01 - EP KR); A61K 2300/00 (2013.01 - IL KR)

C-Set (source: EP)

  1. A61K 31/277 + A61K 2300/00
  2. A61K 31/519 + A61K 2300/00
  3. A61K 31/506 + A61K 2300/00

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2022155543 A1 20220721; AU 2022208712 A1 20230810; AU 2022208712 A9 20240919; BR 112023014247 A2 20231003; CA 3205212 A1 20220721; CN 116981451 A 20231031; EP 4277613 A1 20231122; IL 304467 A 20230901; JP 2024503718 A 20240126; KR 20230163362 A 20231130; MX 2023008375 A 20231005

DOCDB simple family (application)

US 2022012631 W 20220114; AU 2022208712 A 20220114; BR 112023014247 A 20220114; CA 3205212 A 20220114; CN 202280021307 A 20220114; EP 22740195 A 20220114; IL 30446723 A 20230713; JP 2023543203 A 20220114; KR 20237027185 A 20220114; MX 2023008375 A 20220114